XERS vs. ITRG
XERS (Xeris Biopharma Holdings, Inc.) and ITRG (Integra Resources Corp) are both stocks. XERS operates in Biotechnology (Healthcare), while ITRG operates in Other Precious Metals & Mining (Basic Materials). Over the past 5 years, XERS returned 16.00%/yr vs -21.04%/yr for ITRG. At a 0.12 correlation, their price movements are largely independent.
Performance
XERS vs. ITRG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XERS achieves a 6.24% return, which is significantly higher than ITRG's -44.89% return.
XERS
- 1D
- -3.25%
- 1M
- 22.83%
- 6M
- 5.17%
- YTD
- 6.24%
- 1Y
- 63.21%
- 3Y*
- 51.05%
- 5Y*
- 16.00%
- 10Y*
- —
ITRG
- 1D
- -2.21%
- 1M
- -12.30%
- 6M
- -43.62%
- YTD
- -44.89%
- 1Y
- 50.34%
- 3Y*
- 26.57%
- 5Y*
- -21.04%
- 10Y*
- —
XERS vs. ITRG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
XERS Xeris Biopharma Holdings, Inc. | 6.24% | 131.56% | 44.26% | 76.69% | -54.61% | -40.45% | 86.36% |
ITRG Integra Resources Corp | -44.89% | 360.97% | -17.93% | -33.03% | -70.55% | -45.15% | 0.77% |
Correlation
The correlation between XERS and ITRG is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.12 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Jul 9, 2020 | 0.12 |
Fundamentals
XERS:
$1.44B
ITRG:
$374.10M
XERS:
$0.07
ITRG:
$0.05
XERS:
123.93
ITRG:
43.78
XERS:
4.73
ITRG:
1.62
XERS:
113.86
ITRG:
1.75
XERS:
$314.85M
ITRG:
$247.79M
XERS:
$187.04M
ITRG:
$85.71M
XERS:
$41.72M
ITRG:
$71.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XERS vs. ITRG — Risk / Return Rank
XERS
ITRG
XERS vs. ITRG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Xeris Biopharma Holdings, Inc. (XERS) and Integra Resources Corp (ITRG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XERS | ITRG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.30 | ||
| Sortino ratioReturn per unit of downside risk | +0.31 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.16 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 1.26 | 0.95 | +0.31 |
| Martin ratioReturn relative to average drawdown | 2.17 | 1.92 | +0.25 |
Loading charts...
Drawdowns
XERS vs. ITRG - Drawdown Comparison
The maximum XERS drawdown since its inception was -96.22%, roughly equal to the maximum ITRG drawdown of -93.85%. Use the drawdown chart below to compare losses from any high point for XERS and ITRG.
Loading charts...
Drawdown Indicators
| XERS | ITRG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.22% | -93.85% | -2.37% |
Max Drawdown (1Y)Largest decline over 1 year | -46.57% | -52.38% | +5.81% |
Max Drawdown (3Y)Largest decline over 3 years | -47.20% | -52.38% | +5.18% |
Max Drawdown (5Y)Largest decline over 5 years | -71.63% | -90.80% | +19.17% |
Current DrawdownCurrent decline from peak | -69.37% | -80.36% | +10.99% |
Average DrawdownAverage peak-to-trough decline | -78.94% | -70.64% | -8.30% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 26.92% | 25.74% | +1.18% |
Volatility
XERS vs. ITRG - Volatility Comparison
The current volatility for Xeris Biopharma Holdings, Inc. (XERS) is 11.32%, while Integra Resources Corp (ITRG) has a volatility of 19.15%. This indicates that XERS experiences smaller price fluctuations and is considered to be less risky than ITRG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XERS | ITRG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.32% | 19.15% | -7.83% |
Volatility (6M)Calculated over the trailing 6-month period | 32.65% | 46.51% | -13.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 55.24% | 65.48% | -10.24% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 67.96% | 62.77% | +5.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 79.45% | 60.53% | +18.92% |
Dividends
XERS vs. ITRG - Dividend Comparison
Neither XERS nor ITRG has paid dividends to shareholders.
Financials
XERS vs. ITRG - Financials Comparison
This section allows you to compare key financial metrics between Xeris Biopharma Holdings, Inc. and Integra Resources Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
XERS vs. ITRG - Profitability Comparison
XERS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Xeris Biopharma Holdings, Inc. reported a gross profit of 0.00 and revenue of 83.13M. Therefore, the gross margin over that period was 0.0%.
ITRG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Integra Resources Corp reported a gross profit of 18.82M and revenue of 60.87M. Therefore, the gross margin over that period was 30.9%.
XERS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Xeris Biopharma Holdings, Inc. reported an operating income of 7.92M and revenue of 83.13M, resulting in an operating margin of 9.5%.
ITRG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Integra Resources Corp reported an operating income of 15.54M and revenue of 60.87M, resulting in an operating margin of 25.5%.
XERS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Xeris Biopharma Holdings, Inc. reported a net income of 2.23M and revenue of 83.13M, resulting in a net margin of 2.7%.
ITRG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Integra Resources Corp reported a net income of 12.38M and revenue of 60.87M, resulting in a net margin of 20.3%.
Frequently Asked Questions
XERS and ITRG have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ITRG has higher volatility (19.15%) compared to XERS (11.32%). In terms of maximum drawdown, XERS dropped -96.22% vs ITRG's -93.85%.
XERS currently has the higher Sharpe Ratio (1.06 vs 0.76), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XERS and ITRG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer